Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL
02 1DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
03 4TAPI NL B.V. Amsterdam NL
04 2AMOLI ORGANICS PRIVATE LIMITED Mumbai IN
05 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
06 1ARCH PHARMALABS LIMITED Mumbai IN
07 1AUROBINDO PHARMA LIMITED Hyderabad IN
08 1BIOCON LIMITED Bengaluru IN
09 1CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram IN
10 1Changzhou Pharmaceutical Factory Changzhou CN
11 1HEC PHARM GMBH Berlin DE
12 1HETERO LABS LIMITED Hyderabad IN
13 1KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto SI
14 2KRKA, d.d., Novo mesto Novo mesto SI
15 1LAURUS LABS LIMITED Hyderabad IN
16 1LUPIN LIMITED Mumbai IN
17 1MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN
18 1MOREPEN LABORATORIES LIMITED Baddi IN
19 1MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor Village IN
20 2NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo CN
21 1SANECA PHARMACEUTICALS A.S. Hlohovec SK
22 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
23 2SYNTHIMED LABS PRIVATE LIMITED Derabassi IN
24 1ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD. Xiangtan Village CN
25 1ZHEJIANG HONGYUAN PHARMACEUTICAL CO., LTD. Taizhou CN
26 1ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai City CN
27 2ZHEJIANG JIANGBEI PHARMACEUTICAL CO., LTD. Taizhou City CN
28 2ZHEJIANG LEPU PHARMACEUTICAL CO., LTD Taizhou City CN
29 1ZYDUS LIFESCIENCES LIMITED Ankleshwar IN
30 3ZYDUS LIFESCIENCES LIMITED Vadodara IN
31 1Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City CN
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Certificate Number : CEP 2010-366 - Rev 07
Status : Valid
Issue Date : 2024-12-10
Type : Chemical
Substance Number : 2191
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : CEP 2011-222 - Rev 02
Status : Valid
Issue Date : 2023-09-11
Type : Chemical
Substance Number : 2191
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 2012-035 - Rev 03
Status : Valid
Issue Date : 2025-07-03
Type : Chemical
Substance Number : 2191
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Atorvastatin Calcium, Process 4, Polymorphic For...
Certificate Number : CEP 2024-238 - Rev 02
Status : Valid
Issue Date : 2025-09-22
Type : Chemical
Substance Number : 2191
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 2018-059 - Rev 01
Status : Valid
Issue Date : 2025-07-15
Type : Chemical
Substance Number : 2191
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 2022-099 - Rev 02
Status : Valid
Issue Date : 2025-06-16
Type : Chemical
Substance Number : 2191
81
PharmaCompass offers a list of Atorvastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Atorvastatin manufacturer or Atorvastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Atorvastatin manufacturer or Atorvastatin supplier.
PharmaCompass also assists you with knowing the Atorvastatin API Price utilized in the formulation of products. Atorvastatin API Price is not always fixed or binding as the Atorvastatin Price is obtained through a variety of data sources. The Atorvastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, including repackagers and relabelers. The FDA regulates (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid supplier is an individual or a company that provides (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid active pharmaceutical ingredient (API) or (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid finished formulations upon request. The (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid suppliers may include (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid API manufacturers, exporters, distributors and traders.
click here to find a list of (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid CEP of the European Pharmacopoeia monograph is often referred to as a (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid Certificate of Suitability (COS). The purpose of a (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid to their clients by showing that a (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid CEP has been issued for it. The manufacturer submits a (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid CEP holder for the record. Additionally, the data presented in the (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid DMF.
A (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid suppliers with CEP (COS) on PharmaCompass.
We have 27 companies offering (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
Get in contact with the supplier of your choice:
